agm, page-10

Q "...does he still consider apricitabine to be "perhaps the top clinical jewel in the Australian biotech industry"

I can tell you his answer now

He is not going to say "no". He will probably say

"I believe it to be one of the top"


Q "...with the ATC's stella results over the last year, is the Chairman now sure of this assessment?"

He cannot say "yes"

He will say "We cannot be sure until the results are received, but I am (quietly) confident"



Mal